Shi B - Search Results

1

ZIC1 is a putative tumor suppressor in thyroid cancer by modulating major signaling pathways and transcription factor FOXO3a.

Qiang W, Zhao Y, Yang Q, Liu W, Guan H, Lv S, Ji M, Shi B, Hou P. Qiang W, et al. Among authors: shi b. J Clin Endocrinol Metab. 2014 Jul;99(7):E1163-72. doi: 10.1210/jc.2013-3729. Epub 2014 Mar 31. J Clin Endocrinol Metab. 2014. PMID: 24684457

2

High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase/akt pathway in thyroid tumors.

Wang Y, Hou P, Yu H, Wang W, Ji M, Zhao S, Yan S, Sun X, Liu D, Shi B, Zhu G, Condouris S, Xing M. Wang Y, et al. Among authors: shi b. J Clin Endocrinol Metab. 2007 Jun;92(6):2387-90. doi: 10.1210/jc.2006-2019. Epub 2007 Apr 10. J Clin Endocrinol Metab. 2007. PMID: 17426084

3

Detection of BRAF mutation on fine needle aspiration biopsy specimens: diagnostic and clinical implications for papillary thyroid cancer.

Guo F, Hou P, Shi B. Guo F, et al. Among authors: shi b. Acta Cytol. 2010 May-Jun;54(3):291-5. doi: 10.1159/000325037. Acta Cytol. 2010. PMID: 20518413

4

Experience with lentivirus-mediated CD40 gene silencing in a mouse model of Graves' disease.

Ye F, Shi B, Wu X, Hou P, Gao L, Ma X, Xu L, Wu L. Ye F, et al. Among authors: shi b. J Endocrinol. 2011 Mar;208(3):285-91. doi: 10.1677/JOE-10-0224. Epub 2010 Dec 8. J Endocrinol. 2011. PMID: 21147892

5

The clinical presentation of autoimmune thyroid disease in men is associated with IL12B genotype.

Walsh JP, Berry J, Liu S, Panicker V, Dayan CM, Brix TH, Hegedüs L, Hou P, Shi B, Morahan G. Walsh JP, et al. Among authors: shi b. Clin Endocrinol (Oxf). 2011 Apr;74(4):508-12. doi: 10.1111/j.1365-2265.2010.03970.x. Clin Endocrinol (Oxf). 2011. PMID: 21198744

6

Induction of murine neonatal tolerance against Graves' disease using recombinant adenovirus expressing the TSH receptor A-subunit.

Wu L, Xun L, Yang J, Xu L, Tian Z, Gao S, Zhang Y, Hou P, Shi B. Wu L, et al. Among authors: shi b. Endocrinology. 2011 Mar;152(3):1165-71. doi: 10.1210/en.2010-0737. Epub 2011 Feb 1. Endocrinology. 2011. PMID: 21285313

7

Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC).

Ji M, Guan H, Gao C, Shi B, Hou P. Ji M, et al. Among authors: shi b. BMC Cancer. 2011 Apr 20;11:147. doi: 10.1186/1471-2407-11-147. BMC Cancer. 2011. PMID: 21507233 Free PMC article.

8

Concomitant hypermethylation of multiple genes in non-small cell lung cancer (NSCLC).

Ji M, Guan H, Shi B, Hou P. Ji M, et al. Among authors: shi b. Folia Histochem Cytobiol. 2011;49(1):132-41. doi: 10.5603/fhc.2011.0019. Folia Histochem Cytobiol. 2011. PMID: 21526500 Free article.

9

Association of promoter methylation with histologic type and pleural indentation in non-small cell lung cancer (NSCLC).

Ji M, Zhang Y, Shi B, Hou P. Ji M, et al. Among authors: shi b. Diagn Pathol. 2011 Jun 4;6:48. doi: 10.1186/1746-1596-6-48. Diagn Pathol. 2011. PMID: 21639921 Free PMC article.

10

Aberrant DNA methylation of drug metabolism and transport genes in nodular goiter.

Zhang L, Shi J, Xu L, Shi B, Hou P, Ji M. Zhang L, et al. Among authors: shi b, shi j. Thyroid Res. 2011 Oct 12;4(1):15. doi: 10.1186/1756-6614-4-15. Thyroid Res. 2011. PMID: 21988780 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,581 results

Search Page

Filters